Tsai Philip 4
4 · Immunome Inc. · Filed Jun 18, 2024
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Tsai Philip
Chief Technology Officer
Transactions
- Award
Stock option (right to buy)
2024-06-17+250,000→ 250,000 totalExercise: $13.15Exp: 2034-06-16→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the options vest on June 17, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.